MONICA GUPTA: Open Payments
NPI 1497436646 · SHELBY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 66 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $490 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $290 |
| ABBVIE INC. | 17 | $209 |
| Axsome Therapeutics, Inc. | 6 | $188 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Neurocrine BioSciences, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| Neuronetics, Inc. | 1 | $35 |
| Tris Pharma Inc | 2 | $34 |
| Corium, LLC | 1 | $25 |
Products named: CAPLYTA, VRAYLAR, Auvelity, REXULTI, Qelbree, INGREZZA, COBENFY, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across OH — which companies pay providers there.
